167. Ikada Y, Tabata Y (1998) Protein release from gelatin matrices. Adv Drug Deliv Rev
31:287–301
168. Li JK, Wang N, Wu XS (1998) Gelatin nanoencapsulation of protein/peptide drugs using an
emulsifier-free emulsion method. J Microencapsul 15:163–172
169. Wheatley DJ, Raco L, Bernacca GM et al (2000) Polyurethane: material for the next
generation of heart valve prostheses? Eur J Cardiothorac Surg 17:440–448
170. Ganta RS, Piesco PN, Long P (2003) Vascularization and tissue infiltration of a biodegradable polyurethane matrix. J Biomed Mater Res 64A:242–248
171. Gangadharam PRJ, Kailasam S, Srinivasan S et al (1994) Experimental chemotherapy of
tuberculosis using single dose treatment with isoniazid in biodegradable polymers. Br J
Antimicrobial Chemotherapy 33:265–271
172. Kailasam S, Wise DL, Gangadharam PRJ (1994) Bioavailability and chemotherapeutic
activity of clofazimine against Mycobacterium avium complex infections in beige mice
following a single implant of a biodegradable polymer. J Antimicrob Chemother 33:273–279
173. Kunou N, Ogura Y, Hashizoe M et al (1996) Biodegradable scleral implant for controlled
intraocular delivery of ganciclovir. Proc Int Symp Control Release Bioact Mater 23:711–712
174. Wang G, Tucker IG, Roberts MS et al (1996) In vitro and in vivo evaluation in rabbits of a
controlled release 5-fluorouracil subconjunctival implant based on poly (D, L-lactide-coglycolide). Pharm Res 13:1059–1064
175. Ramchandani M, Robinson D (1998) In vitro and in vivo release of ciprofloxacin from PLGA
50:50 implants. J Control Release 54:167–175
176. Lin SS, Ueng SW, Liu SJ et al (1999) Development of biodegradable antibiotic delivery
system. Clin Orthop 5:240–250
177. Lemmouchi Y, Schacht E, Kageruka P et al (1998) Biodegradable polyesters for controlled
release of trypanocidal drugs: in vitro and in vivo studies. Biomaterials 19:1827–1837
178. Song CX, Labhasetwar V, Levy RJ (1996) Modulation of release rates from double-layer
poly(lactic-co-glycolic acid) films for periadventital implants in restenosis. Proc Int Symp
Control Release Bioact Mater 23:473–474
179. Hsu Y-Y, Gresser JD, Stewart RR et al (1996) Mechanisms of isoniazid release from poly
(D, L-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam
methods. J Pharm Sci 85:706–713
180. Cheng L, Lei L, Guo S (2010) In vitro and in vivo evaluation of praziquantel loaded implants
based on PEG/PCL blends. Int J Pharm 387:129–138
181. Pandey SK, Banik RM (2011) Extractive fermentation for enhanced production of alkaline
phosphatase from Bacillus licheniformis MTCC 1483 using aqueous two-phase systems.
Bioresour Technol 102:4226–4231
182. Hayashida K, Kanda K, Yaku H et al (2007) Development of an in vivo tissue-engineered,
autologous heart valve (the biovalve): preparation of prototype model. J Thorac Cardiovasc
Surg 134:152–159
183. Daebrtiz HS, Sachweh SJ, Hermanns B et al (2003) Introduction of a flexible polymeric heart
valve prothesis with special design for mitral position. Circulation 108:II-134–II-139
202
S.K. Pandey et al.
31:287–301
168. Li JK, Wang N, Wu XS (1998) Gelatin nanoencapsulation of protein/peptide drugs using an
emulsifier-free emulsion method. J Microencapsul 15:163–172
169. Wheatley DJ, Raco L, Bernacca GM et al (2000) Polyurethane: material for the next
generation of heart valve prostheses? Eur J Cardiothorac Surg 17:440–448
170. Ganta RS, Piesco PN, Long P (2003) Vascularization and tissue infiltration of a biodegradable polyurethane matrix. J Biomed Mater Res 64A:242–248
171. Gangadharam PRJ, Kailasam S, Srinivasan S et al (1994) Experimental chemotherapy of
tuberculosis using single dose treatment with isoniazid in biodegradable polymers. Br J
Antimicrobial Chemotherapy 33:265–271
172. Kailasam S, Wise DL, Gangadharam PRJ (1994) Bioavailability and chemotherapeutic
activity of clofazimine against Mycobacterium avium complex infections in beige mice
following a single implant of a biodegradable polymer. J Antimicrob Chemother 33:273–279
173. Kunou N, Ogura Y, Hashizoe M et al (1996) Biodegradable scleral implant for controlled
intraocular delivery of ganciclovir. Proc Int Symp Control Release Bioact Mater 23:711–712
174. Wang G, Tucker IG, Roberts MS et al (1996) In vitro and in vivo evaluation in rabbits of a
controlled release 5-fluorouracil subconjunctival implant based on poly (D, L-lactide-coglycolide). Pharm Res 13:1059–1064
175. Ramchandani M, Robinson D (1998) In vitro and in vivo release of ciprofloxacin from PLGA
50:50 implants. J Control Release 54:167–175
176. Lin SS, Ueng SW, Liu SJ et al (1999) Development of biodegradable antibiotic delivery
system. Clin Orthop 5:240–250
177. Lemmouchi Y, Schacht E, Kageruka P et al (1998) Biodegradable polyesters for controlled
release of trypanocidal drugs: in vitro and in vivo studies. Biomaterials 19:1827–1837
178. Song CX, Labhasetwar V, Levy RJ (1996) Modulation of release rates from double-layer
poly(lactic-co-glycolic acid) films for periadventital implants in restenosis. Proc Int Symp
Control Release Bioact Mater 23:473–474
179. Hsu Y-Y, Gresser JD, Stewart RR et al (1996) Mechanisms of isoniazid release from poly
(D, L-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam
methods. J Pharm Sci 85:706–713
180. Cheng L, Lei L, Guo S (2010) In vitro and in vivo evaluation of praziquantel loaded implants
based on PEG/PCL blends. Int J Pharm 387:129–138
181. Pandey SK, Banik RM (2011) Extractive fermentation for enhanced production of alkaline
phosphatase from Bacillus licheniformis MTCC 1483 using aqueous two-phase systems.
Bioresour Technol 102:4226–4231
182. Hayashida K, Kanda K, Yaku H et al (2007) Development of an in vivo tissue-engineered,
autologous heart valve (the biovalve): preparation of prototype model. J Thorac Cardiovasc
Surg 134:152–159
183. Daebrtiz HS, Sachweh SJ, Hermanns B et al (2003) Introduction of a flexible polymeric heart
valve prothesis with special design for mitral position. Circulation 108:II-134–II-139
202
S.K. Pandey et al.